Nana Li

机构：Chengdu Medical College · ORCID：0000-0003-2879-6664

发表论文 29 篇 · 总被引 525 次 · h-index 15

代表论文

• Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders (2021 · Frontiers in Pharmacology · 被引 49)
• Histamine 2/3 receptor agonists alleviate perioperative neurocognitive disorders by inhibiting microglia activation through the PI3K/AKT/FoxO1 pathway in aged rats (2020 · Journal of Neuroinflammation · 被引 40)
• Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia (2022 · Schizophrenia · 被引 33)
• Laparotomy-Induced Peripheral Inflammation Activates NR2B Receptors on the Brain Mast Cells and Results in Neuroinflammation in a Vagus Nerve-Dependent Manner (2022 · Frontiers in Cellular Neuroscience · 被引 28)
• Regulatory Molecules of Synaptic Plasticity in Anxiety Disorder (2023 · International Journal of General Medicine · 被引 25)
• Prognostic value of liver and kidney function parameters and their correlation with the ratio of urine‐to‐plasma paraquat in patients with paraquat poisoning (2021 · Basic & Clinical Pharmacology & Toxicology · 被引 25)